Evidence map›Paper›PMID 33422270›Full record

ArticleInternational journal of radiation oncology, biology, physics2021

Randomized Trials for Esophageal, Liver, Pancreas, and Rectal Cancers.

Christopher L Hallemeier, Florence Huguet, Diana Tait, Michael H Buckstein, Christopher J Anker, Jordan Kharofa, Jeffrey R Olsen, Salma K Jabbour

Abstract readComment
PubMed Publisher
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Christopher L HallemeierDepartment of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
Florence HuguetDepartment of Radiation Oncology, Tenon Hospital, Paris Sorbonne University, Paris, France.
Diana TaitDepartment of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Michael H BucksteinDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Christopher J AnkerUniversity of Vermont Larner College of Medicine, Burlington, Vermont.
Jordan KharofaDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Jeffrey R OlsenDepartment of Radiation Oncology, University of Colorado, Aurora, Colorado.
Salma K JabbourDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey. Electronic address: jabbousk@cinj.rutgers.edu.

Funding

Dr. Salma Jabbour’s NCI Research Specialist (Clinician Scientist) Award (R50)R50CA275877 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Salma Jabbour · 2023 to 2026
$785k
NCI NIH HHS R50 CA275877
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pancreatic NeoplasmsRectal NeoplasmsChemoradiotherapyHumansLiverPancreasRandomized Controlled Trials as Topic

Identifiers

PMID33422270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.